From: Oral contraceptives and hypertension in women: results of the enrolment phase of Tabari Cohort Study
Variables (epidemiological characteristics) | Oral contraceptive use | pĀ value (Chi square or Independent T test) | ||
---|---|---|---|---|
Yes (nā=ā2520 ) | No (nā=ā3453) | |||
Age group | 35ā39 | 13.0 | 19.2 | <ā0.001 |
40ā49 | 36.7 | 34.5 | ||
50ā59 | 33.2 | 28.9 | ||
60ā70 | 17.1 | 17.4 | ||
BMI | <ā25 | 13.8 | 20.0 | <ā0.001 |
25-29.9 | 40.6 | 39.6 | ||
ā„ā30 | 45.5 | 40.4 | ||
WC | <ā88 | 25.8 | 33.5 | <ā0.001 |
ā„ā88 | 74.2 | 66.5 | ||
Social economic level | 1 | 22.6 | 23.1 | 0.011 |
2 | 21.2 | 20.1 | ||
3 | 21.2 | 19.6 | ||
4 | 19.4 | 18.2 | ||
5 | 15.6 | 18.9 | ||
residence area | Urban | 63.5 | 69.0 | <ā0.001 |
Mountainous | 36.5 | 31.0 | ||
Educational level | University/college | 12.6 | 20.2 | <ā0.001 |
9ā12 years in school | 24.2 | 26.7 | ||
6ā8 years in school | 11.4 | 9.2 | ||
1ā5 years in school | 31.8 | 24.2 | ||
No schooling | 20.0 | 19.7 | ||
Parity | <ā2 | 3.0 | 13.6 | <ā0.001 |
2ā3 | 45.1 | 43.1 | ||
4ā5 | 31.7 | 20.2 | ||
>ā5 | 20.2 | 23.1 | ||
Menopause | No | 52.1 | 56.8 | <ā0.001 |
Yes | 47.9 | 43.2 | ||
HDL | ā„ā50 | 60.0 | 58.4 | 0.230 |
<ā50 | 40.0 | 41.6 | ||
TG | <ā150 | 61.0 | 62.2 | 0.314 |
ā„ā150 | 39.0 | 37.8 | ||
TC | <ā200 | 59.6 | 61.5 | 0.148 |
ā„ā200 | 40.4 | 38.5 | ||
Met | <Median | 47.3 | 54.0 | <ā0.001 |
ā„Median | 52.7 | 46.0 | ||
Diabetes | No | 79.2 | 83.6 | <ā0.001 |
Yes | 20.8 | 16.4 | ||
Family history of hypertension | No | 41.9 | 42.8 | 0.482 |
Yes | 58.1 | 57.2 | ||
Breastfeeding, meanāĀ±āSD; month | 66.2āĀ±ā39.4 | 59.9āĀ±ā41.7 | <ā0.001 |